Gelonghui, May 13丨Gongdong Medical (605369.SH) announced that recently, Gongdong, Zhengzhou obtained a “Business License” issued by the Market Supervision Administration of the Zhengzhou Airport Economic Comprehensive Pilot Zone. The registered capital of Zhengzhou Gongdong is RMB 60 million, of which the company has pledged RMB 42 million, accounting for 70% of the registered capital; Antu Biotech has pledged a capital of RMB 18 million, accounting for 30% of the registered capital. An important customer of the shareholder Antu Biotech.

Gongdong, Zhengzhou, which was invested and established by the company this time, will focus on R&D, production and sales of medical polymer consumables and related products and services, matching the company's business and strategic planning; it is conducive to extending the company's industrial chain and strengthening the company's market expansion in the Central Plains region using the joint venture and its team's rich experience and market base in the Central Plains region, further improving the company's business layout and enhancing the company's overall competitiveness; further optimizing the company's business structure and asset structure to promote the company's continuous high-quality and steady development.